J Wang, Z Zhang, X Liu, S Shi, J Lv, Y Zhang… - Kidney International …, 2024 - Elsevier
Background Nefecon, the first innovative drug approved by both the US FDA and European
EMA for IgA nephropathy, lacked comprehensive real-world assessments of its adverse …